Induction with upadacitinib in Crohn’s disease: real-world experience from an early-access program in Greece

In a small cohort of resistant CD patients, the short-term clinical efficacy of upadacitinib was high.

Authors

Institutions

Publication Details

Journal
Annals of Gastroenterology
Published
2025-01-01
DOI
https://doi.org/10.20524/aog.2025.0969
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Induction with upadacitinib in Crohn’s disease: real-world experience from an early-access program in Greece

Evgenia Papathanasiou
Annals of Gastroenterology
Inflammatory Bowel Disease
article

Induction with upadacitinib in Crohn’s disease: real-world experience from an early-access program in Greece

Evgenia Papathanasiou
article en

Abstract

In a small cohort of resistant CD patients, the short-term clinical efficacy of upadacitinib was high.

Annals of GastroenterologyVol. 38(3)
Alexandra Hospital (GR)
Zero hunger
Openalex Percentile: Top 88%
Inflammatory Bowel Disease
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Induction with upadacitinib in Crohn’s disease: real-world experience from an early-access program in Greece — Evgenia Papathanasiou · Annals of Gastroenterology (2025) | TGRS Research Map | TGRS